These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 28486884

  • 1. Effect of intravesical botulinum toxin injection on symptoms of autonomic dysreflexia in a patient with chronic spinal cord injury: a case report.
    Jung IY, Mo KI, Leigh JH.
    J Spinal Cord Med; 2019 Nov; 42(6):806-809. PubMed ID: 28486884
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intravesical Botulinum Toxin for Persistent Autonomic Dysreflexia in a Pediatric Patient.
    Lockwood G, Durkee C, Groth T.
    Case Rep Urol; 2016 Nov; 2016():4569684. PubMed ID: 27006855
    [Abstract] [Full Text] [Related]

  • 4. Effects of intravesical onabotulinumtoxinA on bladder dysfunction and autonomic dysreflexia after spinal cord injury: role of nerve growth factor.
    Elkelini MS, Bagli DJ, Fehlings M, Hassouna M.
    BJU Int; 2012 Feb; 109(3):402-7. PubMed ID: 21733076
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia.
    Walter M, Ramirez AL, Lee AH, Rapoport D, Kavanagh A, Krassioukov AV.
    BMJ Open; 2018 Nov 21; 8(11):e024084. PubMed ID: 30467135
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
    Mehta S, Hill D, McIntyre A, Foley N, Hsieh J, Ethans K, Teasell RW, Loh E, Welk B, Wolfe D.
    Arch Phys Med Rehabil; 2013 Aug 21; 94(8):1473-81. PubMed ID: 23632286
    [Abstract] [Full Text] [Related]

  • 12. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.
    Coelho A, Oliveira R, Cruz F, Cruz CD.
    Exp Neurol; 2016 Nov 21; 285(Pt B):159-166. PubMed ID: 27235935
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.
    Tow AM, Toh KL, Chan SP, Consigliere D.
    Ann Acad Med Singap; 2007 Jan 21; 36(1):11-7. PubMed ID: 17285181
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of fesoterodine for prevention of autonomic dysreflexia in patients with neurogenic dysfunction of the bladder after spinal cord injury].
    Salyukov RV, Kamalov AA, Okhobotov DA, Chalyi ME, Frolova MV.
    Urologiia; 2023 Jul 21; (3):47-51. PubMed ID: 37417411
    [Abstract] [Full Text] [Related]

  • 15. Intradetrusor OnabotulinumtoxinA Injections Ameliorate Autonomic Dysreflexia while Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals with Cervical and Upper Thoracic Spinal Cord Injury.
    Walter M, Kran SL, Ramirez AL, Rapoport D, Nigro MK, Stothers L, Kavanagh A, Krassioukov AV.
    J Neurotrauma; 2020 Sep 15; 37(18):2023-2027. PubMed ID: 32631152
    [Abstract] [Full Text] [Related]

  • 16. New therapeutic options for refractory neurogenic detrusor overactivity.
    Giannantoni A, Mearini E, Di Stasi SM, Costantini E, Zucchi A, Mearini L, Fornetti P, Del Zingaro M, Navarra P, Porena M.
    Minerva Urol Nefrol; 2004 Mar 15; 56(1):79-87. PubMed ID: 15195033
    [Abstract] [Full Text] [Related]

  • 17. Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment.
    Chen SF, Chang CH, Kuo HC.
    Spinal Cord; 2016 Oct 15; 54(10):889-894. PubMed ID: 26832760
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of Urethral Sphincter Botulinum Toxin A Injection in Patients with Spinal Cord Injury with Dysuria: A Retrospective Cohort Study.
    Yu WR, Tian JH, Kuo HC.
    Toxins (Basel); 2024 Jul 31; 16(8):. PubMed ID: 39195746
    [Abstract] [Full Text] [Related]

  • 20. Recurrent autonomic dysreflexia due to chronic aortic dissection in an adult male with cervical spinal cord injury.
    Vaidyanathan S, Hughes PL, Oo T, Soni BM.
    ScientificWorldJournal; 2008 Jun 13; 8():604-10. PubMed ID: 18604444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.